Clinical Trial Update: Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone [Phase 2]

View source ↗

Summary

Randomized Phase II trial comparing MTL-CEBPA plus Sorafenib to Sorafenib alone in hepatocellular carcinoma; the study includes patients with Hepatitis B or Hep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatitis C
• Hepatocellular Carcinoma

Drugs mentioned

• MTL-CEBPA
• Sorafenib (Sorafenib)

Snippet

Sponsor: Mina Alpha Limited | Conditions: Hepatocellular Carcinoma, Hepatitis B | Phase 2 | Status: COMPLETED